cloudfront

Report Detail



OtherGlobal Drug–Device Combination Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2541480
  • |
  • 5 November, 2018
  • |
  • Global
  • |
  • 121 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Global Drug–Device Combination Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Drug–Device Combination Products Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Infusion Pumps
  • 1.2.2 Orthopedic Combination Products
  • 1.2.3 Photodynamic Therapy Devices
  • 1.2.4 Transdermal Patches
  • 1.2.5 Drug Eluting Stents
  • 1.2.6 Wound Care Products
  • 1.2.7 Inhalers
  • 1.2.8 Other
  • 1.3 Market Analysis by Applications
  • 1.3.1 Hospital
  • 1.3.2 Clinic
  • 1.3.3 Other
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 Abbott
    • 2.1.1 Business Overview
  • 2.1.2 Drug–Device Combination Products Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Abbott Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Terumo Corporation
  • 2.2.1 Business Overview
  • 2.2.2 Drug–Device Combination Products Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Terumo Corporation Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Stryker Corporation
  • 2.3.1 Business Overview
  • 2.3.2 Drug–Device Combination Products Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Stryker Corporation Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Mylan
  • 2.4.1 Business Overview
  • 2.4.2 Drug–Device Combination Products Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Mylan Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Medtronic
  • 2.5.1 Business Overview
  • 2.5.2 Drug–Device Combination Products Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Medtronic Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 Allergan
  • 2.6.1 Business Overview
  • 2.6.2 Drug–Device Combination Products Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 Allergan Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Boston Scientific
  • 2.7.1 Business Overview
  • 2.7.2 Drug–Device Combination Products Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Boston Scientific Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 Novartis
  • 2.8.1 Business Overview
  • 2.8.2 Drug–Device Combination Products Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 Novartis Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 C.R. Bard
  • 2.9.1 Business Overview
  • 2.9.2 Drug–Device Combination Products Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 C.R. Bard Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.10 Teleflex Incorporated
  • 2.10.1 Business Overview
  • 2.10.2 Drug–Device Combination Products Type and Applications
  • 2.10.2.1 Product A
  • 2.10.2.2 Product B
  • 2.10.3 Teleflex Incorporated Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Drug–Device Combination Products Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Drug–Device Combination Products Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Drug–Device Combination Products Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Drug–Device Combination Products Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Drug–Device Combination Products Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Drug–Device Combination Products Market Analysis by Regions

    • 4.1 Global Drug–Device Combination Products Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Drug–Device Combination Products Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Drug–Device Combination Products Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 4.3 Europe Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 4.5 South America Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 5 North America Drug–Device Combination Products by Countries

    • 5.1 North America Drug–Device Combination Products Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Drug–Device Combination Products Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Drug–Device Combination Products Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 5.3 Canada Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 6 Europe Drug–Device Combination Products by Countries

    • 6.1 Europe Drug–Device Combination Products Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Drug–Device Combination Products Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Drug–Device Combination Products Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 6.3 UK Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 6.4 France Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 6.5 Russia Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 6.6 Italy Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Drug–Device Combination Products by Countries

    • 7.1 Asia-Pacific Drug–Device Combination Products Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Drug–Device Combination Products Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Drug–Device Combination Products Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 7.3 Japan Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 7.4 Korea Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 7.5 India Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 8 South America Drug–Device Combination Products by Countries

    • 8.1 South America Drug–Device Combination Products Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Drug–Device Combination Products Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Drug–Device Combination Products Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Drug–Device Combination Products by Countries

    • 9.1 Middle East and Africa Drug–Device Combination Products Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Drug–Device Combination Products Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Drug–Device Combination Products Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 9.3 UAE Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Drug–Device Combination Products Sales and Growth Rate (2013-2018)
  • 10 Global Drug–Device Combination Products Market Segment by Type

    • 10.1 Global Drug–Device Combination Products Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Drug–Device Combination Products Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Drug–Device Combination Products Revenue and Market Share by Type (2013-2018)
  • 10.2 Infusion Pumps Sales Growth and Price
  • 10.2.1 Global Infusion Pumps Sales Growth (2013-2018)
  • 10.2.2 Global Infusion Pumps Price (2013-2018)
  • 10.3 Orthopedic Combination Products Sales Growth and Price
  • 10.3.1 Global Orthopedic Combination Products Sales Growth (2013-2018)
  • 10.3.2 Global Orthopedic Combination Products Price (2013-2018)
  • 10.4 Photodynamic Therapy Devices Sales Growth and Price
  • 10.4.1 Global Photodynamic Therapy Devices Sales Growth (2013-2018)
  • 10.4.2 Global Photodynamic Therapy Devices Price (2013-2018)
  • 10.5 Transdermal Patches Sales Growth and Price
  • 10.5.1 Global Transdermal Patches Sales Growth (2013-2018)
  • 10.5.2 Global Transdermal Patches Price (2013-2018)
  • 10.6 Drug Eluting Stents Sales Growth and Price
  • 10.6.1 Global Drug Eluting Stents Sales Growth (2013-2018)
  • 10.6.2 Global Drug Eluting Stents Price (2013-2018)
  • 10.7 Wound Care Products Sales Growth and Price
  • 10.7.1 Global Wound Care Products Sales Growth (2013-2018)
  • 10.7.2 Global Wound Care Products Price (2013-2018)
  • 10.8 Inhalers Sales Growth and Price
  • 10.8.1 Global Inhalers Sales Growth (2013-2018)
  • 10.8.2 Global Inhalers Price (2013-2018)
  • 10.9 Other Sales Growth and Price
  • 10.9.1 Global Other Sales Growth (2013-2018)
  • 10.9.2 Global Other Price (2013-2018)
  • 11 Global Drug–Device Combination Products Market Segment by Application

    • 11.1 Global Drug–Device Combination Products Sales Market Share by Application (2013-2018)
    • 11.2 Hospital Sales Growth (2013-2018)
    • 11.3 Clinic Sales Growth (2013-2018)
    • 11.4 Other Sales Growth (2013-2018)

    12 Drug–Device Combination Products Market Forecast (2018-2023)

    • 12.1 Global Drug–Device Combination Products Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Drug–Device Combination Products Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Drug–Device Combination Products Market Forecast (2018-2023)
  • 12.2.2 Europe Drug–Device Combination Products Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Drug–Device Combination Products Market Forecast (2018-2023)
  • 12.2.4 South America Drug–Device Combination Products Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Drug–Device Combination Products Market Forecast (2018-2023)
  • 12.3 Drug–Device Combination Products Market Forecast by Type (2018-2023)
  • 12.3.1 Global Drug–Device Combination Products Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Drug–Device Combination Products Market Share Forecast by Type (2018-2023)
  • 12.4 Drug–Device Combination Products Market Forecast by Application (2018-2023)
  • 12.4.1 Global Drug–Device Combination Products Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Drug–Device Combination Products Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Combination products are therapeutic and diagnostic products that combine drugs, devices, and/or biological products. 

      Scope of the Report:

      The worldwide market for Drug–Device Combination Products is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      This report focuses on the Drug–Device Combination Products in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers

      Abbott

      Terumo Corporation

      Stryker Corporation

      Mylan

      Medtronic

      Allergan

      Boston Scientific

      Novartis

      C.R. Bard

      Teleflex Incorporated

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Infusion Pumps

      Orthopedic Combination Products

      Photodynamic Therapy Devices

      Transdermal Patches

      Drug Eluting Stents

      Wound Care Products

      Inhalers

      Other

      Market Segment by Applications, can be divided into

      Hospital

      Clinic

      Other

      There are 15 Chapters to deeply display the global Drug–Device Combination Products market.

      Chapter 1, to describe Drug–Device Combination Products Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Drug–Device Combination Products, with sales, revenue, and price of Drug–Device Combination Products, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Drug–Device Combination Products, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Drug–Device Combination Products market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Drug–Device Combination Products sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source




      Summary:
      Get latest Market Research Reports on Drug–Device Combination Products . Industry analysis & Market Report on Drug–Device Combination Products is a syndicated market report, published as Global Drug–Device Combination Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Drug–Device Combination Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Add To Cart Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report